Dyne Therapeutics Inc (DYN NASDAQ) stock market data APIs
$13.1184
-0.33(-2.5%)
as of September 16, 2025
Try our APIs with
free plan!
Dyne Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Prev. Close
13.1184
Open
12.7899
High
13.4445
Low
12.8475
52 wk Range
6.36-37.08
Market Cap
1 871 M
Shares Outstanding
142 M
EPS
-0.97
Beta
1.103
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Dyne Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dyne Therapeutics Inc data using free add-ons & libraries
Get Dyne Therapeutics Inc Fundamental Data
Dyne Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -439 036 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-28
- EPS/Forecast: -0.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dyne Therapeutics Inc News
New
Raymond James Increases PT on Dyne Therapeutics Stock from $31 to $35, Maintains Buy Rating
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 14 Best Small Cap Stocks to Buy Right Now. On August 25, Raymond James increased the price target on Dyne Therapeutics, Inc. (NASDAQ:DYN) stock from ...
Implied IWV Analyst Target Price: $410
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, an...
Dyne Therapeutics to Present at Upcoming Investor Conferences
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driv...
Stocks Settle Lower as Bond Yields Rise
The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.43%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.77%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.31%. ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
